| Home > Publications Database > Interferon-γ induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5 in macrophages. > print |
| 001 | 137434 | ||
| 005 | 20240321220240.0 | ||
| 024 | 7 | _ | |a 10.1111/jnc.12668 |2 doi |
| 024 | 7 | _ | |a pmid:24479685 |2 pmid |
| 024 | 7 | _ | |a 0022-3042 |2 ISSN |
| 024 | 7 | _ | |a 1471-4159 |2 ISSN |
| 024 | 7 | _ | |a altmetric:2213602 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-03756 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Kuß, Martin |0 P:(DE-2719)2801327 |b 0 |e First author |
| 245 | _ | _ | |a Interferon-γ induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5 in macrophages. |
| 260 | _ | _ | |a Oxford |c 2014 |b Wiley-Blackwell |
| 264 | _ | 1 | |3 online |2 Crossref |b Wiley |c 2014-02-24 |
| 264 | _ | 1 | |3 print |2 Crossref |b Wiley |c 2014-06-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1591615548_4057 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a The gene encoding leucine-rich repeat kinase 2 (LRRK2) comprises a major risk factor for Parkinson's disease. Recently, it has emerged that LRRK2 plays important roles in the immune system. LRRK2 is induced by interferon-γ (IFN-γ) in monocytes, but the signaling pathway is not known. Here, we show that IFN-γ-mediated induction of LRRK2 was suppressed by pharmacological inhibition and RNA interference of the extracellular signal-regulated kinase 5 (ERK5). This was confirmed by LRRK2 immunostaining, which also revealed that the morphological responses to IFN-γ were suppressed by ERK5 inhibitor treatment. Both human acute monocytic leukemia THP-1 cells and human peripheral blood monocytes stimulated the ERK5-LRRK2 pathway after differentiation into macrophages. Thus, LRRK2 is induced via a novel, ERK5-dependent IFN-γ signal transduction pathway, pointing to new functions of ERK5 and LRRK2 in human macrophages. Leucine-rich repeat kinase 2 (LRRK2) is a major risk factor for the development of Parkinson's disease (PD). However, the role of LRRK2 in the affected neurons remains enigmatic. Recently, LRRK2 has been reported to be strongly expressed in the immune system. Here, we demonstrate that LRRK2 is induced by Interferon gamma via extracellular signal-regulated kinase 5 (ERK5) in macrophages, thus providing new insights in LRRK2 and ERK5 biology. |
| 536 | _ | _ | |a 344 - Clinical and Health Care Research (POF3-344) |0 G:(DE-HGF)POF3-344 |c POF3-344 |f POF III |x 0 |
| 536 | _ | _ | |a 345 - Population Studies and Genetics (POF3-345) |0 G:(DE-HGF)POF3-345 |c POF3-345 |f POF III |x 1 |
| 542 | _ | _ | |i 2015-09-01 |2 Crossref |u http://doi.wiley.com/10.1002/tdm_license_1.1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a Cytokines |2 NLM Chemicals |
| 650 | _ | 7 | |a Enzyme Inhibitors |2 NLM Chemicals |
| 650 | _ | 7 | |a Interferon-gamma |0 82115-62-6 |2 NLM Chemicals |
| 650 | _ | 7 | |a LRRK2 protein, human |0 EC 2.7.11.1 |2 NLM Chemicals |
| 650 | _ | 7 | |a Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 |0 EC 2.7.11.1 |2 NLM Chemicals |
| 650 | _ | 7 | |a Protein-Serine-Threonine Kinases |0 EC 2.7.11.1 |2 NLM Chemicals |
| 650 | _ | 7 | |a Mitogen-Activated Protein Kinase 7 |0 EC 2.7.11.24 |2 NLM Chemicals |
| 650 | _ | 2 | |a Protein Serine-Threonine Kinases: biosynthesis |2 MeSH |
| 650 | _ | 2 | |a Blotting, Western |2 MeSH |
| 650 | _ | 2 | |a Cells, Cultured |2 MeSH |
| 650 | _ | 2 | |a Cytokines: metabolism |2 MeSH |
| 650 | _ | 2 | |a Enzyme Induction: drug effects |2 MeSH |
| 650 | _ | 2 | |a Enzyme Inhibitors: pharmacology |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Immunohistochemistry |2 MeSH |
| 650 | _ | 2 | |a Interferon-gamma: antagonists & inhibitors |2 MeSH |
| 650 | _ | 2 | |a Interferon-gamma: pharmacology |2 MeSH |
| 650 | _ | 2 | |a Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 |2 MeSH |
| 650 | _ | 2 | |a Macrophages: drug effects |2 MeSH |
| 650 | _ | 2 | |a Macrophages: enzymology |2 MeSH |
| 650 | _ | 2 | |a Mitogen-Activated Protein Kinase 7: antagonists & inhibitors |2 MeSH |
| 650 | _ | 2 | |a Mitogen-Activated Protein Kinase 7: physiology |2 MeSH |
| 650 | _ | 2 | |a Protein-Serine-Threonine Kinases: biosynthesis |2 MeSH |
| 650 | _ | 2 | |a Real-Time Polymerase Chain Reaction |2 MeSH |
| 650 | _ | 2 | |a Signal Transduction: drug effects |2 MeSH |
| 700 | 1 | _ | |a Adamopoulou, Eleni |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Kahle, Philipp J |0 P:(DE-2719)2810803 |b 2 |e Last author |
| 773 | 1 | 8 | |a 10.1111/jnc.12668 |b : Wiley, 2014-02-24 |n 6 |p 980-987 |3 journal-article |2 Crossref |t Journal of Neurochemistry |v 129 |y 2014 |x 0022-3042 |
| 773 | _ | _ | |a 10.1111/jnc.12668 |g Vol. 129, no. 6, p. 980 - 987 |0 PERI:(DE-600)2020528-4 |n 6 |q 129:6<980 - 987 |p 980-987 |t Journal of neurochemistry |v 129 |y 2014 |x 0022-3042 |
| 909 | C | O | |p VDB |o oai:pub.dzne.de:137434 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2801327 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2810803 |
| 913 | 1 | _ | |a DE-HGF |b Forschungsbereich Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-344 |2 G:(DE-HGF)POF3-300 |v Clinical and Health Care Research |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Forschungsbereich Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-345 |2 G:(DE-HGF)POF3-300 |v Population Studies and Genetics |x 1 |
| 914 | 1 | _ | |y 2014 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J NEUROCHEM : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 920 | _ | _ | |l no |
| 920 | 1 | _ | |0 I:(DE-2719)1240015 |k AG N.N. 3 |l AG N.N. |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1210000-4 |k AG Kahle 2 |l Functional Neurogenetics |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1240015 |
| 980 | _ | _ | |a I:(DE-2719)1210000-4 |
| 980 | _ | _ | |a UNRESTRICTED |
| 999 | C | 5 | |a 10.1038/ng.175 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/ng.175 |
| 999 | C | 5 | |a 10.1038/nrn2935 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nrn2935 |
| 999 | C | 5 | |a 10.1016/j.bbrc.2008.11.048 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.bbrc.2008.11.048 |
| 999 | C | 5 | |a 10.1038/nchembio.538 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nchembio.538 |
| 999 | C | 5 | |a 10.1242/jcs.070516 |9 -- missing cx lookup -- |2 Crossref |o 10.1242/jcs.070516 |
| 999 | C | 5 | |a 10.1042/BJ20100784 |9 -- missing cx lookup -- |2 Crossref |o 10.1042/BJ20100784 |
| 999 | C | 5 | |a 10.1128/MCB.01246-12 |9 -- missing cx lookup -- |2 Crossref |o 10.1128/MCB.01246-12 |
| 999 | C | 5 | |a 10.1002/ana.20808 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/ana.20808 |
| 999 | C | 5 | |a 10.4049/jimmunol.1000548 |9 -- missing cx lookup -- |2 Crossref |o 10.4049/jimmunol.1000548 |
| 999 | C | 5 | |a 10.1093/emboj/18.20.5601 |9 -- missing cx lookup -- |2 Crossref |o 10.1093/emboj/18.20.5601 |
| 999 | C | 5 | |a 10.1186/1742-2094-9-94 |9 -- missing cx lookup -- |2 Crossref |o 10.1186/1742-2094-9-94 |
| 999 | C | 5 | |a 10.1007/s00702-011-0653-2 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00702-011-0653-2 |
| 999 | C | 5 | |a 10.1007/s00109-004-0602-8 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00109-004-0602-8 |
| 999 | C | 5 | |a 10.1158/0008-5472.CAN-04-4555 |9 -- missing cx lookup -- |2 Crossref |o 10.1158/0008-5472.CAN-04-4555 |
| 999 | C | 5 | |a 10.1038/ni.2113 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/ni.2113 |
| 999 | C | 5 | |a 10.1111/jnc.12483 |9 -- missing cx lookup -- |2 Crossref |o 10.1111/jnc.12483 |
| 999 | C | 5 | |a 10.1523/JNEUROSCI.5601-11.2012 |9 -- missing cx lookup -- |2 Crossref |o 10.1523/JNEUROSCI.5601-11.2012 |
| 999 | C | 5 | |a 10.1074/jbc.M704079200 |9 -- missing cx lookup -- |2 Crossref |o 10.1074/jbc.M704079200 |
| 999 | C | 5 | |a 10.1042/BJ20091035 |9 -- missing cx lookup -- |2 Crossref |o 10.1042/BJ20091035 |
| 999 | C | 5 | |a 10.1016/j.cellsig.2012.07.007 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.cellsig.2012.07.007 |
| 999 | C | 5 | |a 10.1016/j.neuron.2004.10.023 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.neuron.2004.10.023 |
| 999 | C | 5 | |a 10.1021/cb2002413 |9 -- missing cx lookup -- |2 Crossref |o 10.1021/cb2002413 |
| 999 | C | 5 | |a 10.1038/ng.485 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/ng.485 |
| 999 | C | 5 | |a 10.1038/ng.487 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/ng.487 |
| 999 | C | 5 | |a 10.1042/BST20120151 |9 -- missing cx lookup -- |2 Crossref |o 10.1042/BST20120151 |
| 999 | C | 5 | |a 10.1016/j.bbrc.2008.09.087 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.bbrc.2008.09.087 |
| 999 | C | 5 | |a 10.4049/jimmunol.180.7.4523 |9 -- missing cx lookup -- |2 Crossref |o 10.4049/jimmunol.180.7.4523 |
| 999 | C | 5 | |a 10.1038/icb.2012.9 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/icb.2012.9 |
| 999 | C | 5 | |a 10.1016/j.ccr.2010.08.008 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.ccr.2010.08.008 |
| 999 | C | 5 | |a 10.3389/fphys.2012.00171 |9 -- missing cx lookup -- |2 Crossref |o 10.3389/fphys.2012.00171 |
| 999 | C | 5 | |a 10.1016/S1353-8020(11)70056-6 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S1353-8020(11)70056-6 |
| 999 | C | 5 | |a 10.1056/NEJMoa0903753 |9 -- missing cx lookup -- |2 Crossref |o 10.1056/NEJMoa0903753 |
| 999 | C | 5 | |a 10.1016/j.bmcl.2012.01.084 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.bmcl.2012.01.084 |
| 999 | C | 5 | |a 10.1016/j.neuron.2004.11.005 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.neuron.2004.11.005 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|